Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide + IFN-beta in Relapsing MS
NCT01252355Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jan 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Jan 2011; status: terminated.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01252355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252355.